PAUL DWYER: Open Payments
NPI 1134589955 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,775 in 153 payments from 17 companies in 2025. Trend: 2023 $2,780 · 2024 $3,544 · 2025 $3,775
Food & beverage: $2,776Consulting: $900Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 32 | $1,585 |
| GENZYME CORPORATION | 21 | $461 |
| ABBVIE INC. | 25 | $392 |
| Lilly USA, LLC | 13 | $228 |
| Incyte Corporation | 10 | $180 |
| Arcutis Biotherapeutics, Inc. | 16 | $179 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 9 | $147 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 5 | $98 |
| UCB, Inc. | 4 | $83 |
Products named: TREMFYA, DUPIXENT, TALTZ, SKYRIZI, RINVOQ, OPZELURA, Zoryve, JUBLIA.
Industry payments across CA — which companies pay providers there.
